Summit Trail Advisors LLC Sells 4,663 Shares of Doximity, Inc. (NASDAQ:DOCS)

Summit Trail Advisors LLC decreased its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 9.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 45,907 shares of the company’s stock after selling 4,663 shares during the period. Summit Trail Advisors LLC’s holdings in Doximity were worth $2,451,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the business. UMB Bank n.a. grew its position in shares of Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after buying an additional 235 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Doximity by 20.6% in the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock worth $93,000 after buying an additional 296 shares during the last quarter. MetLife Investment Management LLC grew its position in shares of Doximity by 0.6% in the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock worth $2,835,000 after buying an additional 363 shares during the last quarter. State of Alaska Department of Revenue grew its position in Doximity by 2.6% during the 4th quarter. State of Alaska Department of Revenue now owns 14,610 shares of the company’s stock worth $780,000 after purchasing an additional 370 shares during the last quarter. Finally, First Horizon Advisors Inc. grew its position in Doximity by 22.5% during the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock worth $91,000 after purchasing an additional 384 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Insider Buying and Selling

In other news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 37.40% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have weighed in on DOCS shares. Leerink Partners raised shares of Doximity from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $60.00 to $90.00 in a research report on Friday. The Goldman Sachs Group lifted their price objective on shares of Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a research note on Monday. Raymond James restated an “outperform” rating and set a $83.00 price objective (up from $65.00) on shares of Doximity in a research note on Friday. Morgan Stanley upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $33.00 to $53.00 in a research note on Thursday, November 14th. Finally, Stephens began coverage on shares of Doximity in a report on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price target for the company. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $64.22.

Doximity Stock Up 4.9 %

Shares of DOCS opened at $83.11 on Tuesday. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $85.21. The firm has a market cap of $15.52 billion, a price-to-earnings ratio of 83.11, a PEG ratio of 4.61 and a beta of 1.39. The business’s 50 day moving average is $56.20 and its two-hundred day moving average is $46.30.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.